While normal APP/PS1 mice do not fully capture the complexity of AD, as occurs in humans with metabolic stress, the enhanced pathological features make metabolically stressed AD mice a more challenging and clinically relevant model for testing the efficacy of potential AD treatments. This evidence concerns the gene APP and Alzheimer disease.